Over Rs 6 Crore Tax Evasion Detected In Pharma Firms In U’khand

Dehradun : (PTI) Nine pharmaceutical manufacturing companies and pharma trading units in Dehradun, Haridwar and Roorkee were raided and bogus billing and tax evasion worth more than Rs 6 crore was detected, the Uttarakhand tax department said on Saturday.

Several of these firms were found to be “fake”, it said.

They produced bogus bills showing they got pharma packing materials from companies based in Delhi, Gujarat and Madhya Pradesh. It was found that they had no records to prove transportation of these materials, the department said in a statement.

Four of these firms were found to be not in existence, and altogether a tax evasion of Rs 6.4 crore was detected, it said.

Their input tax credit worth Rs 2.43 crore was immediately blocked and their bank accounts seized, the department said.

Some of the firms even accepted during investigation that they had defaulted and paid Rs 30 lakh as penalty, it said.

Related Posts

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

New Delhi: AstraZeneca’s India-arm has partnered with National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, to build clinical research capabilities at 25 emerging geographies in a bid to extend…

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into papillary-only non-muscle-invasive bladder cancer (NMIBC). Wednesday’s approval comes nearly three months ahead…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

Governments have moved for Price Transparency in Hospitals to help patients cope with bills

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction